Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder: A Systematic Review and Exploratory Meta-Analysis

By >   Yu Weiping   Detraux Johan   Sweers Kim   >   Correll Christoph U.  

CNS Drugs, Vol. 26, Iss. 9, 2012-09 ,pp. : 733-759

Adis International

Access to resources Recommend Favorite

The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania

By Tarazi Frank I   Neill Jo C  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 1, 2013-01 ,pp. : 93-103

Informa Healthcare

Access to resources Recommend Favorite

Asenapine: A Review of its Use in the Management of Mania in Adults with Bipolar I Disorder

By Chwieduk Claudine M.   Scott Lesley J.  

CNS Drugs, Vol. 25, Iss. 3, 2011-03 ,pp. : 251-267

Adis International

Access to resources Recommend Favorite

Olanzapine: In Adolescents with Schizophrenia or Bipolar I Disorder

By McCormack Paul L.  

CNS Drugs, Vol. 24, Iss. 5, 2010-05 ,pp. : 443-452

Adis International

Access to resources Recommend Favorite

Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice

By Fagiolini Andrea   Forgione Rocco N   Morana Benedetto   Maccari Mauro   Goracci Arianna   Bossini Letizia   Pellegrini Francesca   Cuomo Alessandro   Casamassima Francesco  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 4, 2013-03 ,pp. : 489-504

Informa Healthcare

Access to resources Recommend Favorite